Shoreline Biosciences Competitors and Similar CompaniesClear all

Shoreline Biosciences's competitors and similar companies include TScan Therapeutics, NextCure, Secura Bio and Fusion Pharmaceuticals.

	Shoreline Biosciences Shoreline Biosciences is a biotechnology company that provides proprietary cell therapy technology platforms.	TScan Therapeutics TScan Therapeutics is a biotechnology company that develops cancer-targeting therapies.	NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.	Secura Bio Secura Bio is an integrated biopharmaceutical company dedicated to the commercialization of oncology therapies.	Fusion Pharmaceuticals Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer.
Founding Date	Founding Date 2020	Founding Date 2018	Founding Date 2015	Founding Date 2019	Founding Date 2014
Type	Type Private	Type Public	Type Public	Type Private	Type Subsidiary
Tags	Tags Technology biotech oncology pharma therapy	Tags Technology biotech oncology pharma therapy	Tags Healthcare Technology biotech drug development oncology pharma platform therapy	Tags Healthcare Technology biotech oncology pharma therapy	Tags Technology biotech oncology pharma therapy
Locations	Locations San Diego, US HQ San Diego, US	Locations Waltham, US HQ	Locations Beltsville, US HQ	Locations Las Vegas, US HQ San Diego, US	Locations Hamilton, CA HQ Boston, US
Employees	Employees 4716% decrease	Employees 7316% increase	Employees N/A	Employees 489% increase	Employees 101
Valuation ($)	Valuation ($) N/A	Valuation ($) 251.6 m	Valuation ($) 39.2 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $10.3m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $2.1m (FY, 2023)
Net income	Net income N/A	Net income ($129.8m) (FY, 2025)	Net income ($55.8m) (FY, 2025)	Net income N/A	Net income ($94.9m) (FY, 2023)
Funding
Latest funding round	Latest funding round $ 43m (about 5 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 55m (about 7 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 46m	Total funding raised $ 137.5m	Total funding raised $ 160m	Total funding raised $ 195m	Total funding raised $ 170.9m